Skip to main content

Current Hepatology Reports

Ausgabe 4/2017

Inhalt (18 Artikel)

Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)

Autoimmune Hepatitis-Induced by Drugs: a Challenging Diagnosis

Einar S. Björnsson

Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)

Biochemical and Molecular Mechanisms of Liver Damage-Induced by Antidepressant Drugs: an Update Review

Ayantika Pal, Dijendra Nath Roy

Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)

Acute Liver Failure Induced by Anti-infectious Drugs: Causes and Management

Harshad Devarbhavi

Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)

Hepatotoxicity in Patients with Metabolic Syndrome: Causes and Consequences

Jose Ignacio Vargas, Juan Pablo Arab, Fernando Bessone, Maria Isabel Lucena, Raul J. Andrade, Marco Arrese

Drug-Induced Liver Injury (F Bessone and R Andrade, Section Editors)

Hepatotoxicity of New Antitumor Agents

Nelia Hernandez

Open Access Fatty Liver Disease (S Harrison and J George, Section Editors)

Imaging-Based Assessment of Steatosis, Inflammation and Fibrosis in NAFLD

Timothy Hardy, Stuart McPherson

Fatty Liver Disease (S Harrison and J George, Section Editors)

Wet Biomarker-Based Assessment of Steatosis, Inflammation, and Fibrosis in NAFLD

Peter Lykke Eriksen, Karen Louise Thomsen, Tea Lund Laursen, Konstantin Kazankov, Sara Heebøll, Henning Grønbæk

Fatty Liver Disease (S Harrison and J George, Section Editors)

Recent Advances in the Pathogenesis of Hepatitis C Virus-Related Non-Alcoholic Fatty Liver Disease and Its Impact on Patients Cured of Hepatitis C

Takumi Kawaguchi, Hironori Koga, Takuji Torimura

Fatty Liver Disease (S Harrison and J George, Section Editors)

Managing the Burden of Non-NASH NAFLD

Christopher J. Danford, Jorge E. Sanchez, Kathleen E. Corey

Fatty Liver Disease (S Harrison and J George, Section Editors)

Genetic and Epigenetic Associations of NAFLD: Focus on Clinical Decision Making

Mayada Metwally, Mohammed Eslam, Jacob George

Fatty Liver Disease (S Harrison and J George, Section Editors)

What Is the Optimal Dietary Composition for NAFLD?

Elena S. George, Audrey C. Tierney, Katrina L. Campbell, Graeme A. Macdonald, Ingrid J. Hickman

Fatty Liver Disease (S Harrison and J George, Section Editors)

Role of Exercise in NAFLD/NASH: What is the Right Prescription?

Luis Calzadilla Bertot, Leon Anton Adams

Fatty Liver Disease (S Harrison and J George, Section Editors)

Overview of Clinical Treatment Trials for NASH

Monica A. Konerman, Stephen A. Harrison

Fatty Liver Disease (S Harrison and J George, Section Editors)

Managing HCC in NAFLD

Darren Hiu-Sun Foog, Deborah Kwok, Becky Ching-Yeung Yu, Vincent Wai-Sun Wong

Fatty Liver Disease (S Harrison and J George, Section Editors)

Non-alcoholic Fatty Liver Disease in Non-obese Patients

Christopher J. Schmoyer, Mohammad S. Siddiqui

Open Access Fatty Liver Disease (S Harrison and J George, Section Editors)

Natural History of NAFLD/NASH

Mattias Ekstedt, Patrik Nasr, Stergios Kechagias

Portal Hypertension (E Tsochatzis and J Abraldes, Section Editors)

Endoscopic Therapy for Variceal Bleeding: from Patient Preparation to Available Techniques and Rescue Therapies

Philippe Sultanik, Dominique Thabut

Open Access Portal Hypertension (E Tsochatzis and J Abraldes, Section Editors)

The Management of Bleeding from Anorectal Varices

Marcus Robertson, Alexandra Ines Thompson, Peter Clive Hayes

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.